Analysts, who are highly bullish on the stock, have fretted for some time that Viking needed a partner to actually make the ...

Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...

Viking announced a supply deal with CordenPharma that sets it up for a standalone path to the obesity market. Read why I ...

Key Takeaways Viking Holdings shares dropped Tuesday as executives warned of macroeconomic "uncertainties" on the cruise ...

Minnesota and the longtime Viking agreed upon a reworked contract for the 2025 season allowing him to return for another year ...

Viking Holdings (NYSE:VIK) reports robust Q4 growth with a 20.5% sales surge and plans to expand in 2025. Discover key ...

Less than a year after CordenPharma earmarked a major chunk of change to beef up in peptide manufacturing for GLP-1s and ...

The biotech will commit $150 million to an alliance that hands it significant production capacity for a closely watched ...

Viking set new booking and revenue records, continuing strong performance from 2024, with high demand and successful ...

Partnership is expected to support Phase III development of VK2735 in patients with obesity and metabolic disorders amid ...